- Evaluation of intraaxial enhancing brain tumors on magnetic resonance imaging: intraindividual crossover comparison of gadobenate dimeglumine and gadopentetate dimeglumine for visualization and assessment, and implications for surgical interventionMatthew J Kuhn
Department of Radiology, Southern Illinois University School of Medicine, Springfield, Illinois 62769, USA
J Neurosurg 106:557-66. 2007..1 mmol/kg doses of gadobenate dimeglumine (Gd-BOPTA) and gadopentetate dimeglumine, also known as gadolinium diethylenetriamine pentaacetic acid (Gd-DTPA), for enhanced magnetic resonance (MR) imaging of intraaxial brain tumors...
- The PREDICT study: a randomized double-blind comparison of contrast-induced nephropathy after low- or isoosmolar contrast agent exposureMatthew J Kuhn
Department of Radiology, Southern Illinois University School of Medicine, 800 E Carpenter St, Springfield, IL 62769, USA
AJR Am J Roentgenol 191:151-7. 2008....
- Contrast enhancement of central nervous system lesions: multicenter intraindividual crossover comparative study of two MR contrast agentsKenneth R Maravilla
Neuroradiology and MR Research Laboratory, University of Washington, Box 357115, 1959 NE Pacific St, Seattle, WA 98195, USA
Radiology 240:389-400. 2006..To prospectively compare gadobenate dimeglumine with gadopentetate dimeglumine (0.1 mmol per kilogram body weight) for enhanced magnetic resonance (MR) imaging of central nervous system (CNS) lesions...